Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.

I have tried a variety of mascaras in my time, but Glossier’s Lash Slick has been my go-to for many years now, and the moment the beauty brand released a brown version of the iconic make-up ...

Eli Lilly LLY.N plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with the ...

Eli Lilly said Wednesday it will invest $27 billion to build four new manufacturing plants in the United States as the pharmaceutical giant grapples with the threat of drug import duties from the ...

“I love Lilly Lashes for strip lashes,” says Lilly Keys. The brand offers sheer band, 3D mink and self-adhesive options for a range of lengths and flutter styles. For individual ...

Eli Lilly (LLY) and Company announced at plans to bolster its domestic medicine production across therapeutic areas by building four new pharmaceutical manufacturing sites in the United States.

Eli Lilly (LLY) has agreed to acquire Organovo Holdings’ (ONVO) FXR program, including its main drug candidate FXR314, to expand its IBD (inflammatory bowel disease) treatment pipeline.

Eli Lilly is unleashing new ammunition in its fight against cheaper, compounded versions of its obesity blockbuster Zepbound. The Indiana-based drugmaker is slashing the prices of its 2.5 mg ...